| |
Baseline values
|
Difference between arms at baseline (P-value)
|
|---|
|
Age (years)
|
57 (48, 63)
|
0.01
|
|
Weight (kg)
|
65 (62, 78)
|
0.43
|
|
BMI (kg/m2)
|
24 (21, 27)
|
0.89
|
|
WC (cm)
|
88 (84, 94)
|
0.91
|
|
BIA (%)
|
31 (27, 40)
|
0.99
|
|
VFR (%)
|
11 (8, 12)
|
0.91
|
|
SBP (mmHg)
|
120 (120, 130)
|
0.54
|
|
DBP (mmHg)
|
80 (80, 80)
|
0.88
|
|
HR (bpm)
|
64 (60, 68)
|
0.24
|
|
TC (mg/mL)
|
271 (247, 288)
|
0.51
|
|
LDL-C (mg/mL)
|
180 (170, 196)
|
0.29
|
|
HDL-C (mg/mL)
|
60 (43, 77)
|
0.51
|
|
Non-HDL-C (mg/mL)
|
210 (193, 228)
|
0.24
|
|
TG (mg/mL)
|
115 (94, 150)
|
0.79
|
|
apoAI (mg/dL)
|
118 (95, 133)
|
0.28
|
|
apoB (mg/dL)
|
146 (134, 155)
|
0.07
|
|
oxLDL (U/L)
|
76.6 (69.7, 86.7)
|
0.08
|
|
Lp(a) (mg/dL)
|
6 (4, 12)
|
0.32
|
|
PCSK9 (ng/dL)
|
341 (285, 403)
|
0.81
|
|
FPG (mg/dL)
|
95 (89, 98)
|
0.97
|
|
Insulin (mUI/L)
|
3.38 (2.46, 4.92)
|
0.64
|
|
HOMA-IR
|
0.75 (0.57, 1.15)
|
0.72
|
|
FGF19 (pg/mL)
|
227 (173, 337)
|
0.87
|
|
FGF21 (pg/mL)
|
179 (119, 229)
|
0.37
|
- Statistically significant P-values are indicated in bold
- BMI body mass index, WC waist circumference, BIA bioelectrical impedance analysis, VFR visceral fat rating, SBP Systolic blood pressure, DBP diastolic blood pressure, HR heart rate, TC total cholesterol, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, TG triglycerides, apoA-I apolipoprotein A-I, apoB apolipoprotein B, oxLDL oxidize LDL, Lp(a) lipoprotein (a), PCSK9 proprotein convertase subtilisin/kexin type 9, FPG fasting plasma glucose, sICAM-1 soluble intercellular adhesion molecular 1, HOMA-IR Homeostatic Model Assessment of Insulin Resistance, FGF fibroblast growth factor
